U.S. Markets closed
  • S&P Futures

    +4.25 (+0.11%)
  • Dow Futures

    +39.00 (+0.12%)
  • Nasdaq Futures

    -40.25 (-0.34%)
  • Russell 2000 Futures

    -3.40 (-0.19%)
  • Crude Oil

    +0.46 (+0.42%)
  • Gold

    +3.90 (+0.21%)
  • Silver

    -0.03 (-0.13%)

    -0.0026 (-0.2429%)
  • 10-Yr Bond

    -0.0680 (-2.38%)
  • Vix

    +0.08 (+0.27%)

    +0.0020 (+0.1587%)

    +0.0560 (+0.0438%)

    -860.55 (-2.86%)
  • CMC Crypto 200

    -23.03 (-3.42%)
  • FTSE 100

    +87.24 (+1.19%)
  • Nikkei 225

    +336.19 (+1.27%)

Axxess Pharma Enters Into Manufacturing Agreement With SDC Nutrition -- cGMP Certified and FDA Registered

TORONTO, ON--(Marketwired - Dec 8, 2015) - Axxess Pharma Inc. (OTC PINK: AXXE) a specialty pharmaceutical and nutritional supplements company, is pleased to announce they have entered into a manufacturing agreement with SDC Nutrition (SDC). SDC is a turnkey, in-house, FDA registered, Health Canada approved and cGMP Certified facility. The facility specializes in reformulating and manufacturing powdered, nutritional products. These products include whey proteins, pre-workouts and plant based proteins.

Under the agreement, SDC has reformulated and immediately begun manufacturing all of Axxess Pharma's Tapout protein powders. These protein powders include their two pound tubs of Chocolate Turbo Blend, Vanilla Cream Turbo Blend, Café Latte Turbo Blend and Pre-Workout Fruit Punch. SDC will be shipping the first order of products this month.

Bruce Barger, Director of Contract Manufacturing for SDC Nutrition stated, "We are excited to provide our turnkey manufacturing and reformulating services to Axxess Pharma, Inc. The Tapout brand is known for being all-natural, innovative and superior in quality. We look forward to assisting Axxess Pharma in providing the product needs of all of their customer throughout North America."

Daniel Bagi, M.D. President of Axxess stated, "We are honored to have SDC manufacture our all-natural Tapout product line. They are known throughout the industry for maintaining the highest of quality product controls."

About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess Pharma, Inc. is a specialty health care products company dedicated to improving health and quality of life by offering select medicines, all-natural nutritional supplements and over the counter remedies all across the Americas. Axxess Pharma holds the Tapout license to sell all-natural, globally branded nutraceutical products, including pain relief sprays and wipes. The company's goal is to bring additional products to the market and provide new, innovative options for better health spanning across areas such as high cholesterol, blood pressure, acute pain, -- to optimal health management through improved nutritional supplements. One of Axxes's buyers of Tapout products, include the US military.

For more information, please visit https://tapoutmusclerecovery.com, or contact Investor Relations at (973) 351-3868.

To view all Axxess Pharma social media sites, please click any of the following links:
http://facebook.com/tapoutmusclerecovery, http://twitter.com/tapoutmusclerec, http://instagram.com/tapoutmusclerecovery.

About SDC Nutrition:
SDC nutrition was founded by having our protein powders manufactured by others, however after multiple contract manufacturing issues regarding delivery times, identity of products and others, SDC made the decision to manufacture all powder products, such as whey proteins, pre workouts and plant based proteins; in house to ensure quality. We offer these same services and turnkey manufacturing practices that we take pride in for our own products for you as well. We know how important it is to deal with business partners and manufacturers you can trust who do what they say they will do and that's the core of what we deliver. For more information, please visit: http://sdcnutrition.com/

Safe Harbor Statement

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.